Toops
Dana S. Toops, Parkland, FL US
Patent application number | Description | Published |
---|---|---|
20100087520 | STABLE SOLUTIONS OF ORLISTAT FOR PHARMACEUTICAL DOSAGE FORMS - Liquid orlistat-containing fill materials suitable for encapsulating in hard or soft capsules are described herein. The fill material contains orlistat dissolved in one or more medium chain triglycerides or medium chain partial triglycerides, one or more citrate esters, and combinations thereof. The fill material can also contain one or more pharmaceutically acceptable excipients. In one embodiment, the fill material is substantially free of surfactants. The fill material can be encapsulated in hard or soft, gelatin or non-gelatin capsules. The capsules may be coated to modify release of orlistat from the capsule. Alternatively, the fill material can be encapsulated in an enteric capsule, wherein the enteric polymer is a component of the capsule shell, rather than a coating over the capsule shell. The fill materials are stable at elevated temperatures over an extended period of time and allow for high loadings of orlistat (e.g., 20% w/w or higher). | 04-08-2010 |
20100255085 | Progesterone Solutions for Increased Bioavailability - Fill materials for hydrophobic drugs, such as progesterone, and methods of making and using thereof are described herein. The fill material contains the hydrophobic drug dissolved in one or more fatty acids. The concentration of the hydrophobic drug is typically from about 7% to about 50% by weight of the fill material. The concentration of the one or more fatty acids is from about 60% to about 95% by weight of the carrier. The formulation also contains an organic acid and one or both of one or more pharmaceutically acceptable alcohols and one or more pharmaceutically acceptable mono-, di-, or triesters of medium or long chain fatty acids. The fill material can be encapsulated in a hard or soft capsule. The formulations described herein have a higher dissolution rate and faster onset of dissolution compared to micronized progesterone suspended in an oil and thus should have increased bioavailability in vivo. | 10-07-2010 |
David J. Toops, Terrell, TX US
Patent application number | Description | Published |
---|---|---|
20100211853 | High Reliability and Low Power Redundancy for Memory - An integrated circuit containing a memory array, a redundancy circuit and a redundancy error correction circuit coupled to said redundancy circuit. A method for constructing a redundancy word which corresponds to each memory segment and a method for error checking the redundancy word during a memory access request. | 08-19-2010 |
20110231736 | Low-Power Redundancy for Non-Volatile Memory - A static RAM redundancy memory for use in combination with a non-volatile memory array, such as ferroelectric RAM (FRAM), in which the power consumption of the SRAM redundancy memory is reduced. Each word of the redundancy memory includes data bit cells for storing addresses of memory cells in the FRAM array to be replaced by redundant elements, and also enable bits indicating whether redundancy is enabled for those addresses. A logical combination of the enable bits in a given word determines whether the data bit cells in that word are powered-up. As a result, the power consumption of the redundancy memory is reduced to the extent that redundancy is not enabled for segments of the FRAM array. | 09-22-2011 |
David J. Toops, Lucas, TX US
Patent application number | Description | Published |
---|---|---|
20130258751 | FRAM COMPILER AND LAYOUT - A computer program for generating a layout for a ferroelectric random access memory (FRAM) that is embodied on a non-transitory storage medium and executable by a processor is provided. FRAM specifications are received, and an FRAM floorplan and design rules are retrieved from the non-transitory storage medium. The layout for the FRAM based on the FRAM specifications and design rules is then assembled. | 10-03-2013 |
Eric A. Toops, Dacula, GA US
Patent application number | Description | Published |
---|---|---|
20090030978 | MEDIA CONTENT DEVICE AND SYSTEM - A device for obtaining media content from a source and storing the media content for subsequent playback. A response mechanism enables a listener to generate response information associated with particular media content that is being rendered by the device. This response information can be delivered to a third party system for triggering the performance of specific actions related to the media content. A content system interfaces to the device and to the Internet. The content system obtains media content from one or more sources via the Internet and delivers the content to the device. | 01-29-2009 |
Kimberly A. Toops, Sun Prairie, WI US
Patent application number | Description | Published |
---|---|---|
20150366876 | Use of Inhibitors of Acid Sphingomyelinase to Treat Acquired and Inherited Retinal Degenerations - A method of treating retinal diseases is disclosed that includes the step of administering an effective amount of a composition including an ASMase inhibitor to a retinal disease patient, wherein at least one disease symptom is either lessened or progression of the symptom is delayed. | 12-24-2015 |
Todd J. Toops, Knoxville, TN US
Patent application number | Description | Published |
---|---|---|
20150273444 | Catalysts for Low Temperature Oxidation - The invention provides a composite catalyst containing a first component and a second component. The first component contains nanosized gold particles. The second component contains nanosized platinum group metals. The composite catalyst is useful for catalyzing the oxidation of carbon monoxide, hydrocarbons, oxides of nitrogen, and other pollutants at low temperatures. | 10-01-2015 |